{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:45:33Z","timestamp":1793213133615,"version":"4.5.0"},"reference-count":24,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Renal Failure"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/0886022x.2022.2097405","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T21:26:14Z","timestamp":1657661174000},"page":"1124-1130","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Rituximab for the treatment of refractory anti-glomerular basement membrane disease"],"prefix":"10.1080","volume":"44","author":[{"given":"Xue-Fen","family":"Yang","sequence":"first","affiliation":[{"name":"Renal Division, Peking University First Hospital","place":["Beijing, China"]},{"name":"Renal Division, Shanxi Medical University Second Hospital, Shanxi Kidney Disease Institute","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Jia","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital","place":["Beijing, China"]},{"name":"Institute of Nephrology, Peking University","place":["Beijing, China"]},{"name":"Key Laboratory of Renal Disease, Ministry of Health of China","place":["Beijing, China"]},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China","place":["Beijing, China"]},{"name":"Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Juan","family":"Yu","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital","place":["Beijing, China"]},{"name":"Institute of Nephrology, Peking University","place":["Beijing, China"]},{"name":"Key Laboratory of Renal Disease, Ministry of Health of China","place":["Beijing, China"]},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China","place":["Beijing, China"]},{"name":"Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Cui","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital","place":["Beijing, China"]},{"name":"Institute of Nephrology, Peking University","place":["Beijing, China"]},{"name":"Key Laboratory of Renal Disease, Ministry of Health of China","place":["Beijing, China"]},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China","place":["Beijing, China"]},{"name":"Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University First Hospital","place":["Beijing, China"]},{"name":"Institute of Nephrology, Peking University","place":["Beijing, China"]},{"name":"Key Laboratory of Renal Disease, Ministry of Health of China","place":["Beijing, China"]},{"name":"Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China","place":["Beijing, China"]},{"name":"Research Units of Diagnosis and Treatment of Immune-mediated Kidney Diseases, Chinese Academy of Medical Sciences","place":["Beijing, China"]},{"name":"Peking-Tsinghua Center for Life Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.024"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00720.x"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn179"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-12-21"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2020.1869042"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2011.89"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2020.1854301"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-11-200106050-00009"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017801"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-jbn-2018-0254"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.015"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.10.922"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.10.007"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sft152"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2018.12.002"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcr001"},{"issue":"4","key":"e_1_3_3_18_1","first-page":"421","article-title":"Additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-GBM nephritis","volume":"3","author":"Mutsaers P","year":"2010","unstructured":"Mutsaers P, Selten H, van Dam B. Additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-GBM nephritis. NDT Plus. 2010;3(4):421\u2013422.","journal-title":"NDT Plus"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-240543"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.04.003"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-018-1038-7"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2018.04.015"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-206220"},{"issue":"3","key":"e_1_3_3_24_1","first-page":"225","article-title":"Rituximab in two cases of Goodpasture\u2019s syndrome","volume":"2","author":"Schless B","year":"2009","unstructured":"Schless B, Yildirim S, Beha D, et\u00a0al. Rituximab in two cases of Goodpasture\u2019s syndrome. NDT Plus. 2009;2(3):225\u2013227.","journal-title":"NDT Plus"},{"issue":"4","key":"e_1_3_3_25_1","first-page":"461","article-title":"Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease","volume":"10","author":"Trivin C","year":"2017","unstructured":"Trivin C, Tran A, Moulin B, et\u00a0al. Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease. Clin Kidney J. 2017;10(4):461\u2013469.","journal-title":"Clin Kidney J"}],"container-title":["Renal Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/0886022X.2022.2097405","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/0886022X.2022.2097405","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/0886022X.2022.2097405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:56:59Z","timestamp":1790834219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/0886022X.2022.2097405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/0886022X.2022.2097405"],"URL":"https:\/\/doi.org\/10.1080\/0886022x.2022.2097405","relation":{},"ISSN":["0886-022X","1525-6049"],"issn-type":[{"value":"0886-022X","type":"print"},{"value":"1525-6049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irnf20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irnf20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}